PVI
KRTX

Pura Vida Investments’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Pura Vida Investments’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-29,900
Closed -$3.78M – 267
2022
Q2 		$3.78M Buy
+29,900
New +$3.44M 0.22% 106

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Pura Vida Investments's KRTX Position: Q3 2022 in Review

Pura Vida Investments sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2022, closing a stake of 29,900 shares — an estimated $3.78M sold.

Pura Vida Investments first reported a position in KRTX in Q2 2022 and held it in 1 quarter. The position peaked at $3.78M in Q2 2022. 257 funds tracked by Wall St. Rank hold KRTX as of Q3 2022.

  • Pura Vida Investments reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Pura Vida Investments sold 29,900 Karuna Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $3.78M.
  • Pura Vida Investments first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Pura Vida Investments's Karuna Therapeutics, Inc. Common Stock position peaked at $3.78M in Q2 2022.
  • 257 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.